ArriVent BioPharma, Inc. SEC filings and other documents

Explore the latest company documents and SEC filings from ArriVent BioPharma, Inc., including Forms 10-K, 10-Q, 8-K, and other key disclosures. Evaluate financial performance and operational updates to make more informed decisions.

Description

Event date

Documents and forms

2025

Q2 2025

Aug 11, 2025

Quarterly report10-Q

Earnings release8-K

Study Update

Jun 23, 2025

Slides

Press release

Q1 2025

May 12, 2025

Quarterly report10-Q

Earnings release8-K

2024

Q4 2024

Mar 3, 2025

Earnings release8-K

Annual report10-K

Q3 2024

Nov 14, 2024

Quarterly report10-Q

Earnings release8-K

Q2 2024

Aug 14, 2024

Quarterly report10-Q

Earnings release8-K

Q1 2024

May 8, 2024

Quarterly report10-Q

Earnings release8-K

2023

Q4 2023

Mar 28, 2024

Annual report10-K